Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Nanomolar-potency 'co-potentiator' therapy for cystic fibrosis caused by a defined subset of minimal function CFTR mutants.

Phuan PW, Tan JA, Rivera AA, Zlock L, Nielson DW, Finkbeiner WE, Haggie PM, Verkman AS.

Sci Rep. 2019 Nov 27;9(1):17640. doi: 10.1038/s41598-019-54158-2.

2.

Regional variations in longitudinal pulmonary function: A comparison of Hispanic and non-Hispanic subjects with cystic fibrosis in the United States.

McGarry ME, Neuhaus JM, Nielson DW, Ly NP.

Pediatr Pulmonol. 2019 Sep;54(9):1382-1390. doi: 10.1002/ppul.24377. Epub 2019 May 29.

PMID:
31144477
3.

Phylogenomic Analysis of Extraintestinal Pathogenic Escherichia coli Sequence Type 1193, an Emerging Multidrug-Resistant Clonal Group.

Johnson TJ, Elnekave E, Miller EA, Munoz-Aguayo J, Flores Figueroa C, Johnston B, Nielson DW, Logue CM, Johnson JR.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01913-18. doi: 10.1128/AAC.01913-18. Print 2019 Jan.

4.

Combination potentiator ('co-potentiator') therapy for CF caused by CFTR mutants, including N1303K, that are poorly responsive to single potentiators.

Phuan PW, Son JH, Tan JA, Li C, Musante I, Zlock L, Nielson DW, Finkbeiner WE, Kurth MJ, Galietta LJ, Haggie PM, Verkman AS.

J Cyst Fibros. 2018 Sep;17(5):595-606. doi: 10.1016/j.jcf.2018.05.010. Epub 2018 Jun 12.

5.

Pulmonary function disparities exist and persist in Hispanic patients with cystic fibrosis: A longitudinal analysis.

McGarry ME, Neuhaus JM, Nielson DW, Burchard E, Ly NP.

Pediatr Pulmonol. 2017 Dec;52(12):1550-1557. doi: 10.1002/ppul.23884. Epub 2017 Oct 30.

6.

In vivo and in vitro ivacaftor response in cystic fibrosis patients with residual CFTR function: N-of-1 studies.

McGarry ME, Illek B, Ly NP, Zlock L, Olshansky S, Moreno C, Finkbeiner WE, Nielson DW.

Pediatr Pulmonol. 2017 Apr;52(4):472-479. doi: 10.1002/ppul.23659. Epub 2017 Jan 9.

7.

Correctors and Potentiators Rescue Function of the Truncated W1282X-Cystic Fibrosis Transmembrane Regulator (CFTR) Translation Product.

Haggie PM, Phuan PW, Tan JA, Xu H, Avramescu RG, Perdomo D, Zlock L, Nielson DW, Finkbeiner WE, Lukacs GL, Verkman AS.

J Biol Chem. 2017 Jan 20;292(3):771-785. doi: 10.1074/jbc.M116.764720. Epub 2016 Nov 28.

8.
9.

Antibiotic prescribing during pediatric ambulatory care visits for asthma.

Paul IM, Maselli JH, Hersh AL, Boushey HA, Nielson DW, Cabana MD.

Pediatrics. 2011 Jun;127(6):1014-21. doi: 10.1542/peds.2011-0218. Epub 2011 May 23.

PMID:
21606155
10.

Airway surface liquid depth measured in ex vivo fragments of pig and human trachea: dependence on Na+ and Cl- channel function.

Song Y, Namkung W, Nielson DW, Lee JW, Finkbeiner WE, Verkman AS.

Am J Physiol Lung Cell Mol Physiol. 2009 Dec;297(6):L1131-40. doi: 10.1152/ajplung.00085.2009. Epub 2009 Oct 9.

11.

Should inhaled beta-agonists or lung function testing be routine in prematurely born infants with chronic lung disease?

Wu B, Nielson DW.

Pediatr Crit Care Med. 2008 Nov;9(6):662-4. doi: 10.1097/PCC.0b013e31818c8412. No abstract available.

PMID:
18997602
12.

Glycosylation of sputum mucins is altered in cystic fibrosis patients.

Schulz BL, Sloane AJ, Robinson LJ, Prasad SS, Lindner RA, Robinson M, Bye PT, Nielson DW, Harry JL, Packer NH, Karlsson NG.

Glycobiology. 2007 Jul;17(7):698-712. Epub 2007 Mar 28.

PMID:
17392389
13.

Hyperacidity of secreted fluid from submucosal glands in early cystic fibrosis.

Song Y, Salinas D, Nielson DW, Verkman AS.

Am J Physiol Cell Physiol. 2006 Mar;290(3):C741-9. Epub 2005 Oct 5.

14.

Proteomic analysis of sputum from adults and children with cystic fibrosis and from control subjects.

Sloane AJ, Lindner RA, Prasad SS, Sebastian LT, Pedersen SK, Robinson M, Bye PT, Nielson DW, Harry JL.

Am J Respir Crit Care Med. 2005 Dec 1;172(11):1416-26. Epub 2005 Sep 15.

PMID:
16166615
15.

Submucosal gland dysfunction as a primary defect in cystic fibrosis.

Salinas D, Haggie PM, Thiagarajah JR, Song Y, Rosbe K, Finkbeiner WE, Nielson DW, Verkman AS.

FASEB J. 2005 Mar;19(3):431-3. Epub 2004 Dec 13.

PMID:
15596485
16.

CFTR involvement in nasal potential differences in mice and pigs studied using a thiazolidinone CFTR inhibitor.

Salinas DB, Pedemonte N, Muanprasat C, Finkbeiner WF, Nielson DW, Verkman AS.

Am J Physiol Lung Cell Mol Physiol. 2004 Nov;287(5):L936-43. Epub 2004 Jul 9.

17.

Health values of adolescents with cystic fibrosis.

Yi MS, Britto MT, Wilmott RW, Kotagal UR, Eckman MH, Nielson DW, Kociela VL, Tsevat J.

J Pediatr. 2003 Feb;142(2):133-40.

PMID:
12584533
18.

Idiopathic congenital central hypoventilation syndrome: the next generation.

Silvestri JM, Chen ML, Weese-Mayer DE, McQuitty JM, Carveth HJ, Nielson DW, Borowitz D, Cerny F.

Am J Med Genet. 2002 Sep 15;112(1):46-50.

PMID:
12239719
19.

Topical lidocaine exaggerates laryngomalacia during flexible bronchoscopy.

Nielson DW, Ku PL, Egger M.

Am J Respir Crit Care Med. 2000 Jan;161(1):147-51.

PMID:
10619812
20.

Effectiveness of home versus hospital care in the routine treatment of cystic fibrosis.

Bosworth DG, Nielson DW.

Pediatr Pulmonol. 1997 Jul;24(1):42-7.

PMID:
9261852
21.

Eliminating sleep-associated hypoxemia improves growth in infants with bronchopulmonary dysplasia.

Moyer-Mileur LJ, Nielson DW, Pfeffer KD, Witte MK, Chapman DL.

Pediatrics. 1996 Oct;98(4 Pt 1):779-83.

PMID:
8885961
22.

Changes in lung lipid during spontaneous labor in fetal sheep.

Chapman DL, Carlton DP, Nielson DW, Cummings JJ, Poulain FR, Bland RD.

J Appl Physiol (1985). 1994 Feb;76(2):523-30.

PMID:
8175558
23.

Risk of sudden infant death from gastroesophageal reflux.

Nielson DW.

J Pediatr Surg. 1992 Mar;27(3):417-9. No abstract available.

PMID:
1501018
24.

Developmental changes in lung epithelial ion transport and liquid movement.

Bland RD, Nielson DW.

Annu Rev Physiol. 1992;54:373-94. Review.

PMID:
1314041
25.

Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis.

LiPuma JJ, Dasen SE, Nielson DW, Stern RC, Stull TL.

Lancet. 1990 Nov 3;336(8723):1094-6.

PMID:
1977981
26.

Stridor and gastroesophageal reflux in infants.

Nielson DW, Heldt GP, Tooley WH.

Pediatrics. 1990 Jun;85(6):1034-9.

PMID:
2339026
27.

Effects of amiloride on alveolar epithelial PD and fluid composition in rabbits.

Nielson DW, Lewis MB.

Am J Physiol. 1990 Apr;258(4 Pt 1):L215-9.

PMID:
2333979
28.

Mask ventilation in congenital central alveolar hypoventilation syndrome.

Nielson DW, Black PG.

Pediatr Pulmonol. 1990;9(1):44-5. No abstract available.

PMID:
2201939
29.

Calcium increases in pulmonary alveolar fluid in lambs at birth.

Nielson DW, Lewis MB.

Pediatr Res. 1988 Sep;24(3):322-5.

PMID:
3211617
30.
31.

Technology dependent children in the home.

Andrews MM, Nielson DW.

Pediatr Nurs. 1988 Mar-Apr;14(2):111-4, 151. No abstract available.

PMID:
3353136
32.

Effect of disodium cromoglycate on neutrophil movement and intracellular calcium mobilization.

Skedinger MC, Augustine NH, Morris EZ, Nielson DW, Zimmerman GA, Hill HR.

J Allergy Clin Immunol. 1987 Oct;80(4):573-7.

PMID:
3117863
33.

Home apnea monitoring in the Intermountain West.

Andrews MM, Nuttall PR, Nielson DW.

J Pediatr Health Care. 1987 Sep-Oct;1(5):255-60. No abstract available.

PMID:
3656041
34.

Electrolyte composition of pulmonary alveolar subphase in anesthetized rabbits.

Nielson DW.

J Appl Physiol (1985). 1986 Mar;60(3):972-9.

PMID:
3957848
35.

Effects of inspired CO2 on skin surface CO2 measurements.

East KA, Nielson DW.

J Pediatr. 1984 Aug;105(2):274-6. No abstract available.

PMID:
6431067
36.

Alveolar subphase pH in the lungs of anesthetized rabbits.

Nielson DW, Goerke J, Clements JA.

Proc Natl Acad Sci U S A. 1981 Nov;78(11):7119-23.

Supplemental Content

Loading ...
Support Center